Stock Research: Max Healthcare Institute

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Max Healthcare Institute

BSE:543220 INE027H01010
17
  • Value
    26
  • Growth
    89
  • Safety
    Safety
    3
  • Combined
    17
  • Sentiment
    33
  • 360° View
    360° View
    17
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Max Healthcare Institute Limited is an India-based integrated healthcare provider specializing in advanced cardiac care, orthopedics, oncology, neurosciences, and more, also offering outpatient and diagnostic services through Max Lab and Max@Home. It operates across Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. In the last fiscal year, the company had 15114 employees, a market cap of $14319 million, profits of $636 million, and revenue of $823 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 17 (better than 17% compared with alternatives), overall professional sentiment and financial characteristics for the stock Max Healthcare Institute are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Max Healthcare Institute. The consolidated Growth Rank has a good rank of 89, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 89% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 3 means that the share price of Max Healthcare Institute is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 97% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 26, which means that the company has a riskier financing structure than 74% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 33, indicating professional investors are more pessimistic about the stock than for 67% of alternative investment opportunities. ...read more

more
Index
Moonshot Tech
Robotics
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 3 6 7
Growth
89 79 97 99
Safety
Safety
26 46 58 24
Sentiment
33 55 63 32
360° View
360° View
17 34 67 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
47 53 59 100
Opinions Change
9 43 59 50
Pro Holdings
n/a 74 39 1
Market Pulse
54 66 74 33
Sentiment
33 55 63 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 3 6 7
Growth
89 79 97 99
Safety Safety
26 46 58 24
Combined
17 26 65 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 7 12 22
Price vs. Earnings (P/E)
6 3 7 17
Price vs. Book (P/B)
16 12 24 26
Dividend Yield
20 14 12 1
Value
3 3 6 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 94 89 53
Profit Growth
92 65 44 100
Capital Growth
23 27 95 91
Stock Returns
89 81 89 100
Growth
89 79 97 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
41 52 68 60
Refinancing
14 11 23 17
Liquidity
48 72 61 16
Safety Safety
26 46 58 24

Similar Stocks

Discover high‑ranked alternatives to Max Healthcare Institute and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

NMDC

BSE:526371
Country: India
Industry: Steel
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.